Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine …

MR Meyer, J Wilhelm, FT Peters, HH Maurer - Analytical and bioanalytical …, 2010 - Springer
In recent years, a new class of designer drugs has appeared on the drugs of abuse market in
many countries, namely, the so-called beta-keto (bk) designer drugs such as mephedrone (…

Studies on the metabolism of the α‐pyrrolidinophenone designer drug methylenedioxy‐pyrovalerone (MDPV) in rat and human urine and human liver microsomes …

MR Meyer, P Du, F Schuster… - Journal of Mass …, 2010 - Wiley Online Library
Since the late 1990s, many derivatives of the α‐pyrrolidinophenone (PPP) drug class
appeared on the drugs of abuse market. The latest compound was described in 2009 to be a …

Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives

…, J Kinyua, FY Lai, T Letzel, L Lopardo, MR Meyer… - Environment …, 2017 - Elsevier
The information obtained from the chemical analysis of specific human excretion products (biomarkers)
in urban wastewater can be used to estimate the exposure or consumption of the …

Ion suppression and enhancement effects of co‐eluting analytes in multi‐analyte approaches: systematic investigation using ultra‐high‐performance liquid …

D Remane, MR Meyer, DK Wissenbach… - … in Mass Spectrometry, 2010 - Wiley Online Library
In multi‐analyte procedures, sufficient separation is important to avoid interferences, particularly
when using liquid chromatography/mass spectrometry (LC/MS) because of possible ion …

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

DK Wissenbach, MR Meyer, D Remane… - Analytical and …, 2011 - Springer
Today, immunoassays and several chromatographic methods are in use for drug screening
in clinical and forensic toxicology and in doping control. For further proof of the authors’ new …

Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine

MR Meyer, FT Peters, HH Maurer - Clinical chemistry, 2010 - academic.oup.com
Background: The challenge in systematic toxicological analysis using gas chromatography
and/or liquid chromatography coupled to mass spectrometry is to identify compounds of …

Orbitrap technology for comprehensive metabolite-based liquid chromatographic–high resolution-tandem mass spectrometric urine drug screening–Exemplified for …

AG Helfer, JA Michely, AA Weber, MR Meyer… - Analytica chimica …, 2015 - Elsevier
LC–high resolution (HR)-MS well established in proteomics has become more and more
important in bioanalysis of small molecules over the last few years. Its high selectivity and …

Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse

MR Meyer, HH Maurer - Pharmacogenomics, 2011 - Future Medicine
Pharmacologic and toxic effects of xenobiotics, such as drugs of abuse, depend on the
genotype and phenotype of an individual, and conversely on the isoenzymes involved in their …

Development of the first metabolite-based LC-MS n urine drug screening procedure-exemplified for antidepressants

DK Wissenbach, MR Meyer, D Remane… - Analytical and …, 2011 - Springer
In contrast to GC-MS libraries, currently available LC-MS libraries for toxicological detection
contain besides parent drugs only some main metabolites limiting their applicability for urine …

Metabolism of designer drugs of abuse: an updated review

MR Meyer, HH Maurer - Current drug metabolism, 2010 - ingentaconnect.com
This paper reviews the metabolism of new designer drugs of abuse that have emerged on
the black market during the last years and is an update of a review published in 2005. The …